BDBM499330 5-chloro-4-((3-(6- (cyclopropylmethoxy)pyridin-3- yl)phenoxy)methyl)-2-fluoro-N- (thiophen-2- ylsulfonyl)benzamide::US11020381, Example 20

SMILES Fc1cc(COc2cccc(c2)-c2ccc(OCC3CC3)nc2)c(Cl)cc1C(=O)NS(=O)(=O)c1cccs1

InChI Key InChIKey=NOBNLTTZTTXJSN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 499330   

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandPNGBDBM499330(5-chloro-4-((3-(6- (cyclopropylmethoxy)pyridin-3- ...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent